RxDoctor Payments Data

Jeannine Dannenbaum, NP

Adult Health · Camarillo, CANPI 1417253550

Payments from drug & device makers

$981in general payments, 2019–2025

Across 48 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$426
  • AbbVie$190
  • Vertex$60
  • Indivior Inc.$58
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$43
  • Johnson & Johnson$29
  • plus $175 from 9 others

What the payments were for

  • Food & beverage$981100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$981 in reported general payments places this provider in the 70th percentile of 785 adult health providers in California.

See all adult health providers in California

Medicare billing

Part B allowed, 2024
$75,255
Medicare patients
182
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl348$69,087
Buprenorphine167$46,232
SuboxoneBuprenorphine Hcl/Naloxone Hcl44$28,701
UbrelvyUbrogepant19$23,446
Aimovig AutoinjectorErenumab-Aooe30$21,555
Nurtec OdtRimegepant Sulfate13$17,481
MovantikNaloxegol Oxalate44$17,397
Nucynta ErTapentadol Hcl17$17,386
NucyntaTapentadol Hcl15$16,141
BotoxOnabotulinumtoxina13$15,397
BelbucaBuprenorphine Hcl24$13,851
Lidocaine91$11,491
HorizantGabapentin Enacarbil13$10,986
Gabapentin ErGabapentin11$4,704
Gabapentin250$3,566

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta, Belbuca$426$47,37956 claims
AbbVieUbrelvy, Botox$190$38,84332 claims
Indivior Inc.Suboxone$58$28,70144 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 785 adult health providers in California.

Other adult health in Camarillo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →